Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology

Looking Ahead: Long-Term Monitoring and Family Health

At a Glance

Children with HNF1A-related hyperinsulinism may later develop HNF1A-MODY, a slowly progressive form of diabetes. Lifelong, individualized blood-sugar screening and specialist-guided family genetic testing can detect changes early and clarify risks for relatives.

While the initial focus of care is managing your child’s low blood sugar, a diagnosis of HNF1A-related hyperinsulinism also provides a roadmap for their long-term health. Because this condition can be biphasic (having two phases), your care team will eventually shift their focus from preventing hypoglycemia (low blood sugar) to monitoring for the potential development of diabetes later in life [1][2].

The Transition to HNF1A-MODY

The same genetic change in the HNF1A gene that causes the pancreas to be overactive in infancy can eventually lead to a gradual decline in insulin production [3]. This can result in a form of diabetes called HNF1A-MODY (Maturity-Onset Diabetes of the Young, type 3) [4].

It is important to remember that this transition is often slow and progressive. While the age for the onset of diabetes in people with HNF1A mutations varies significantly by variant and even within the same family, it can happen in the teenage years or adulthood [5][6]. Because of this, lifelong monitoring is essential [5].

Recommended Long-Term Screenings

To catch the transition to diabetes early—often before any symptoms appear—specialists recommend regular “check-ins” with your child’s endocrine system [7]. Common screening tools include:

  • HbA1c: A simple blood test that measures average blood sugar levels over the past 2–3 months [5]. It is not a stand-alone test for infants and may miss early post-meal changes.
  • Fasting Plasma Glucose: A measurement of blood sugar after your child has not eaten for several hours [7].
  • Oral Glucose Tolerance Test (OGTT): A test where your child drinks a sugary liquid, and blood sugar is measured at specific intervals to see how the body processes the sugar load [7].

While there is no single “one-size-fits-all” schedule, many experts recommend individualized screenings based on symptoms and prior results once the neonatal phase has stabilized [5][7]. Ask your endocrinologist what specific abnormal results should trigger a prompt call before the next visit.

Beyond the Pancreas: Liver Health

A rare but important risk associated with HNF1A mutations is the development of liver adenomatosis [8]. This condition involves the growth of adenomas (tumors) in the liver [8].

  • Why Screening Matters: These tumors often do not cause symptoms and may not show up on standard liver blood tests [8]. However, they can sometimes grow or, in rare cases, cause bleeding [8][9].
  • Screening Method: The frequency and value of routine imaging in people with HNF1A variants are uncertain, and systematic screening is not universally recommended. It should follow specialist assessment and an applicable guideline [8]. If a lesion is found, more detailed imaging like an MRI may be used to monitor it [8][10].
  • Urgent Symptoms: Seek urgent care for sudden severe abdominal pain, fainting, or signs of bleeding.

Cascade Testing: Protecting the Whole Family

Because HNF1A-related conditions are autosomal dominant, there are specific inheritance risks [5][11]. If the child has a variant inherited from one parent, that parent carries it, and each sibling has a 50% chance of inheriting it. If the variant is de novo (new in the child), the sibling risk is much lower.

Cascade genetic testing is the process of testing relatives (parents, siblings, and children) for the specific variant found in your child under the guidance of a genetic counselor [12][13]. Testing the parents first often clarifies the sibling risk. This is recommended because:

  1. Early Detection: It can identify family members who may have “silent” diabetes or who are at risk of developing it [14].
  2. Correct Diagnosis: Many family members with HNF1A-MODY are misdiagnosed with Type 1 or Type 2 diabetes. A genetic confirmation can often lead to better, more targeted treatments [15][16].
  3. Informed Planning: It helps other family members make informed decisions about their own health monitoring [13][16].

Working with a genetic counselor can help you navigate these conversations with your family and ensure everyone receives the appropriate testing and follow-up care.

Common questions in this guide

Can HNF1A-related hyperinsulinism lead to diabetes later?
Yes. The same HNF1A gene change that causes excess insulin and low blood sugar early in life can gradually reduce insulin production later, causing HNF1A-MODY, a form of diabetes. The timing varies between genetic variants and families, so lifelong monitoring is important.
Which tests monitor diabetes risk in a child with an HNF1A variant?
Common tests include HbA1c, fasting plasma glucose, and an oral glucose tolerance test. HbA1c estimates average blood sugar over two to three months, but it should not be the only test in infants and may miss early after-meal changes.
How often should a child with HNF1A-related hyperinsulinism be screened for diabetes?
There is no single schedule for every child. After the newborn period has stabilized, the endocrinologist can set an individualized plan based on the child's symptoms, previous results, genetic variant, and family history.
Do HNF1A variants increase the risk of liver tumors?
Rarely, HNF1A variants are associated with liver adenomatosis, in which multiple benign liver tumors called adenomas develop. These lesions may cause no symptoms and may not change routine liver blood tests, so imaging decisions should be based on specialist assessment and applicable guidance.
What symptoms from a possible liver adenoma require urgent care?
Seek urgent medical care for sudden severe abdominal pain, fainting, or signs of bleeding. Liver adenomas can sometimes grow or bleed, and these symptoms need prompt evaluation.
Should parents and siblings have genetic testing for HNF1A?
A genetic counselor can guide cascade testing for parents, siblings, and other relatives using the specific variant found in the child. Testing parents first may clarify whether the variant was inherited and help estimate sibling risk; relatives who carry it can receive appropriate diabetes monitoring.

Get notified when new evidence is published on Hyperinsulinism due to HNF1A deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family.

    Chandran S, Rajadurai VS, Hoi WH, et al.

    Frontiers in pediatrics 2020; (8()):320 doi:10.3389/fped.2020.00320.

    PMID: 32670997
  2. 2

    [Congenital hyperinsulinism: Loss of B-cell self-control].

    Lebl J, Roženková K, Průhová Š

    Vnitrni lekarstvi 2016; (62(11 Suppl 4)):S72-76.

    PMID: 27921429
  3. 3

    Maturity-onset diabetes of the young (MODY): an update.

    Anık A, Çatlı G, Abacı A, Böber E

    Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(3-4)):251-63.

    PMID: 25581748
  4. 4

    Genetic and clinical characteristics of children with mody: insights into novel HNF4A variants and genotype-phenotype correlation.

    Buhur Pirimoglu M, Gundogdu Ogutlu OB, Nursoy H, et al.

    Irish journal of medical science 2025; (194(5)):1605-1615 doi:10.1007/s11845-025-04020-4.

    PMID: 40715678
  5. 5

    Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review.

    Perge K, Nicolino M

    Reviews in endocrine & metabolic disorders 2022; (23(5)):1063-1078 doi:10.1007/s11154-022-09749-2.

    PMID: 35996042
  6. 6

    Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.

    Mirshahi UL, Colclough K, Wright CF, et al.

    American journal of human genetics 2022; (109(11)):2018-2028 doi:10.1016/j.ajhg.2022.09.014.

    PMID: 36257325
  7. 7

    Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins).

    Dubois-Laforgue D, Donadille B, Ciangura C, et al.

    Orphanet journal of rare diseases 2026; (17(Suppl 1)).

    PMID: 42227416
  8. 8

    Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.

    Haddouche A, Bellanne-Chantelot C, Rod A, et al.

    Journal of diabetes 2020; (12(1)):48-57 doi:10.1111/1753-0407.12959.

    PMID: 31166087
  9. 9

    Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.

    Haring MPD, Vriesendorp TM, Klein Wassink-Ruiter JS, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2019; (39(11)):2042-2045 doi:10.1111/liv.14235.

    PMID: 31483937
  10. 10

    Hepatic Adenomatosis: A Systematic Review of Definitions, Management, and Outcomes in Published Cases.

    Stirrat T, Kim S, Bejugam D, et al.

    GE Portuguese journal of gastroenterology 2026; (33(1)):606-619 doi:10.1159/pjg/acwag002.

    PMID: 42923951
  11. 11

    Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?

    Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellanné-Chantelot C

    Canadian journal of diabetes 2016; (40(5)):455-461 doi:10.1016/j.jcjd.2015.12.005.

    PMID: 27103109
  12. 12

    Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY).

    Verma M, Stone SI

    Endocrinology, diabetes & metabolism case reports 2022; (2022()).

    PMID: 35466084
  13. 13

    Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.

    Breidbart E, Deng L, Lanzano P, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(5)):633-638 doi:10.1515/jpem-2020-0501.

    PMID: 33852230
  14. 14

    Novel insights into genetics and clinics of the HNF1A-MODY.

    Valkovicova T, Skopkova M, Stanik J, Gasperikova D

    Endocrine regulations 2019; (53(2)):110-134.

    PMID: 31517624
  15. 15

    Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.

    Brahm AJ, Wang G, Wang J, et al.

    Canadian journal of diabetes 2016; (40(6)):555-560 doi:10.1016/j.jcjd.2016.05.010.

    PMID: 27634015
  16. 16

    Monogenic diabetes and pregnancy.

    Murphy R

    Obstetric medicine 2015; (8(3)):114-20 doi:10.1177/1753495X15590713.

    PMID: 27512465

This page is for informational purposes only and does not constitute medical advice. Your child's endocrinologist and genetic counselor should tailor diabetes, liver, and family screening to your child's results and family history.